Related Experiment Video
Updated: Mar 8, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
'Screen and treat' is not a major help in preventing type 2 diabetes
Abstract:
Policies to 'screen and treat' people to prevent type 2 diabetes are unlikely to have a substantial effect on the growing diabetes epidemic, say researchers from the University of Oxford.
Insights
Screening and treating individuals to prevent type 2 diabetes may not significantly impact the diabetes epidemic. Researchers suggest current policies might be insufficient for widespread prevention efforts.
Area of Science:
- Endocrinology
- Public Health
- Preventive Medicine
Background:
- The global prevalence of type 2 diabetes (T2D) continues to rise, posing a significant public health challenge.
- Current T2D prevention strategies often involve 'screen and treat' approaches targeting individuals at risk.
- The effectiveness of these population-level screening and treatment policies in curbing the epidemic is under scrutiny.
Purpose of the Study:
- To evaluate the potential impact of 'screen and treat' policies on the diabetes epidemic.
- To assess whether widespread screening and early treatment can substantially reduce T2D incidence.
- To inform public health policy regarding T2D prevention.
Main Methods:
- The study likely involved epidemiological modeling or analysis of existing public health data.
- Researchers may have simulated the effect of different screening and treatment thresholds.
- The methodology aimed to quantify the population-level impact on T2D rates.
Main Results:
- Findings suggest that 'screen and treat' policies alone are unlikely to substantially alter the trajectory of the diabetes epidemic.
- The impact of such policies may be limited in scope, failing to address the multifaceted drivers of T2D.
- The study highlights potential limitations in the scalability or efficacy of current preventive measures.
Conclusions:
- 'Screen and treat' strategies may not be sufficient as a standalone solution for the diabetes epidemic.
- A broader, more comprehensive approach to T2D prevention is likely necessary.
- Further research into alternative or complementary prevention strategies is warranted.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Preventive Healthcare Services

